Emerging notions about the microenvironmental control of tumor growth and dissemination;Contrôle de la croissance et de la dissémination tumorales par le microenvironnement

Medecine/Sciences

Volumn 30, Issue 4, 2014, Pages 366-371

  Provot, Sylvain ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; METASTASIS; NEOPLASM; PATHOLOGY; TUMOR CELL CULTURE; TUMOR MICROENVIRONMENT;

HUMANS; NEOPLASM METASTASIS; NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84900316317     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20143004008     Document Type: Article

References (50)

1. Smith C. Cancer shows strength through diversity. Nature 2013; 499: 505-508.
2. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-322.
3. Swartz MA, Iida N, Roberts EW, et al. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 2012; 72: 2473-2480.
4. Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 1989; 8: 98-101.
5. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol 1982; 99: 31-68.
6. Folkman, J. Tumor angiogenesis. Adv Cancer Res 1974; 19: 331-358.
7. Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012; 196: 395-406.
8. Semenza GL. Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis. Oncogene 2013; 32: 4057-4063.
9. Alitalo A, Detmar M. Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 2012; 31: 4499-4508.
10. De Bock K, Cauwenberghs S, Carmeliet P. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications. Curr Opin Genet Dev 2011; 21: 73-79.
11. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
12. Shields JD, Kourtis IC, Tomei AA, et al. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 2010; 328: 749-752.
13. Rattigan YI, Patel BB, Ackerstaff E, et al. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res 2012; 318: 326-335.
14. Levental KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139: 891-906.
15. Chou J, Lin JH, Brenot A, et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat Cell Biol 2013; 15: 201-213.
16. Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol 2010; 222: 42-49.
17. Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009; 9: 285-293.
18. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473: 298-307.
19. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7: 211-217.
20. Guerra C, Collado M, Navas C, et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011; 19: 728-739.
21. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011; 331: 1559-1564.
22. Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 2011; 3.
23. Chen Q, Zhang XH, Massague J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 2011; 20: 538-549.
24. Shree T, Olson OC, Elie BT, et al. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes Dev 2011; 25: 2465-2479.
25. Bochet L, Meulle A, Imbert S, et al. Cancer-associated adipocytes promotes breast tumor radioresistance. Biochem Biophys Res Commun 2011; 411: 102-106.
26. Martinez-Outschoorn UE, Sotgia F, Lisanti, MP. Power surge: supporting cells "fuel" cancer cell mitochondria. Cell Metab 2012; 15: 4-5.
27. Ruffell B, DeNardo DG, Affara, NI, Coussens LM. Lymphocytes in cancer development: polarization towards pro-tumor immunity. Cytokine Growth Factor Rev 2010; 21: 3-10.
28. Stover DG, Bierie B, Moses HL. A delicate balance: TGF-beta and the tumor microenvironment. J Cell Biochem 2007; 101: 851-861.
29. Cooke VG, LeBleu VS, Keskin D, et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 2012; 21: 66-81.
30. Zhang XH, Jin X, Malladi S, et al. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell 2013; 154: 1060-1073.
31. McAllister SS, Gifford AM, Greiner AL, et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 2008; 133: 994-1005.
32. Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011; 20: 576-590.
33. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438: 820-827.
34. Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006; 8: 1369-1375.
35. Dougall WC. Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer Res 2012; 18: 326-335.
36. Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010; 464: 852-857.
37. Hamm CA, Stevens JW, Xie H, et al. Microenvironment alters epigenetic, gene expression profiles in Swarm rat chondrosarcoma tumors. BMC Cancer 2010; 10: 471.
38. Unger M, Weaver VM. The tissue microenvironment as an epigenetic tumor modifier. Methods Mol Biol 2003; 223: 315-347.
39. Fridman WH, Sautès-Fridman C. Le microenvironnement tumoral: matrice nourricière, champ de bataille et cible thérapeutique des cancers. Med Sci (Paris) 2014; 30: 359-365.
40. Le Guellec S, Duprez-Paumier R, Lacroix-Triki M. Microenvironnement tumoral: la vision du pathologiste. Med Sci (Paris) 2014; 30: 372-377.
41. Albrengues J, Meneguzzi G, Gaggioli C. L'invasion des cellules tumorales: quand les fibroblastes s'en mêlent. Med Sci (Paris) 2014; 30: 391-397.
42. Laurent V, Nieto L, Philippe Valet P, Muller C. Tissu adipeux et cancer: une association à haut risque. Med Sci (Paris) 2014; 30: 398-404.
43. Bruchard M, Ghiringhelli F. Microenvironnement tumoral: cellules régulatrices et cytokines immunosuppressives. Med Sci (Paris) 2014; 30: 429-435.
44. Galon J, Bindea G, Mlecnik B, et al. Microenvironnement immunitaire et cancer: intérêt de l'Immunoscore pour prédire l'évolution clinique. Med Sci (Paris) 2014; 30: 439-444.
45. Buache E, Rio MC. Le stroma tumoral, un terreau fertile pour la cellule cancéreuse. Med Sci (Paris) 2014; 30: 385-390.
46. Azzi S, Gavard J. Vaisseaux sanguins et tumeurs ou l'art du dialogue. Med Sci (Paris) 2014; 30: 408-414.
47. Razungles J, Cavaillès V, Jalaguier S, Teyssier C. L'effet Warburg. Med Sci (Paris) 2013; 29: 1026-1033.
48. Borriello L, DeClerck YA. Le microenvironnement tumoral et la résistance thérapeutique. Med Sci (Paris) 2014; 30: 445-451.
49. Fellouse FA. Les exosomes du stroma permettent au cellules cancéreuses de s'auto-activer. Med Sci (Paris) 2014; 30: 405-407.
50. Hubert S, Abastado JP. Les étapes précoces du processus métastatique. Med Sci (Paris) 2014; 30: 378-384.